Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Cited In for PubMed (Select 9709044)

1.

hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines.

Kim SJ, Kim HR, Kim SH, Han JH, Cho YB, Yun SH, Lee WY, Kim HC.

Ann Surg Treat Res. 2014 Sep;87(3):123-30. doi: 10.4174/astr.2014.87.3.123. Epub 2014 Aug 26.

2.

A risk prediction model for smoking experimentation in Mexican American youth.

Talluri R, Wilkinson AV, Spitz MR, Shete S.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2165-74. doi: 10.1158/1055-9965.EPI-14-0467. Epub 2014 Jul 25.

PMID:
25063521
3.

Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes.

Gallego CJ, Bennette CS, Heagerty P, Comstock B, Horike-Pyne M, Hisama F, Amendola LM, Bennett RL, Dorschner MO, Tarczy-Hornoch P, Grady WM, Fullerton SM, Trinidad SB, Regier DA, Nickerson DA, Burke W, Patrick DL, Jarvik GP, Veenstra DL.

Contemp Clin Trials. 2014 Sep;39(1):1-8. doi: 10.1016/j.cct.2014.06.016. Epub 2014 Jul 3.

4.

Hereditary cancer risk assessment: essential tools for a better approach.

Gomy I, Estevez Diz Mdel P.

Hered Cancer Clin Pract. 2013 Oct 28;11(1):16. doi: 10.1186/1897-4287-11-16.

5.

Precancerous lesions in colorectal cancer.

Sandouk F, Al Jerf F, Al-Halabi MH.

Gastroenterol Res Pract. 2013;2013:457901. doi: 10.1155/2013/457901. Epub 2013 May 14.

6.

Identification of patients at risk for hereditary colorectal cancer.

Mishra N, Hall J.

Clin Colon Rectal Surg. 2012 Jun;25(2):67-82. doi: 10.1055/s-0032-1313777.

7.

Prediction models in Lynch syndrome.

Kastrinos F, Balmaña J, Syngal S.

Fam Cancer. 2013 Jun;12(2):217-28. doi: 10.1007/s10689-013-9632-0. Review.

8.

Identification of Lynch syndrome among patients with colorectal cancer.

Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A; EPICOLON Consortium.

JAMA. 2012 Oct 17;308(15):1555-65. doi: 10.1001/jama.2012.13088.

9.

Clinical and pathological tools for identifying microsatellite instability in colorectal cancer.

Krivokapić Z, Marković S, Antić J, Dimitrijević I, Bojić D, Svorcan P, Jojić N, Damjanović S.

Croat Med J. 2012 Aug;53(4):328-35.

10.

Hereditary aspects of colon cancer.

Wills JC, Burt RW.

Ochsner J. 2002 Summer;4(3):129-38.

11.

Screening for Familial Colorectal Cancer Risk amongst Colonoscopy Patients New to an Open-Access Endoscopy Center.

Moole S, McGarrity TJ, Baker MJ.

ISRN Gastroenterol. 2012;2012:152980. doi: 10.5402/2012/152980. Epub 2012 Mar 22.

12.

Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries.

Monteiro Santos EM, Valentin MD, Carneiro F, de Oliveira LP, de Oliveira Ferreira F, Junior SA, Nakagawa WT, Gomy I, de Faria Ferraz VE, da Silva Junior WA, Carraro DM, Rossi BM.

BMC Cancer. 2012 Feb 9;12:64. doi: 10.1186/1471-2407-12-64.

13.

Pancreatic cancer and a novel MSH2 germline alteration.

Lindor NM, Petersen GM, Spurdle AB, Thompson B, Goldgar DE, Thibodeau SN.

Pancreas. 2011 Oct;40(7):1138-40. doi: 10.1097/MPA.0b013e318220c217.

14.

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K.

CA Cancer J Clin. 2011 Sep-Oct;61(5):327-59. doi: 10.3322/caac.20128. Epub 2011 Aug 19. Review.

15.

Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.

Koehler-Santos P, Izetti P, Abud J, Pitroski CE, Cossio SL, Camey SA, Tarta C, Damin DC, Contu PC, Rosito MA, Ashton-Prolla P, Prolla JC.

World J Gastroenterol. 2011 Feb 14;17(6):766-73. doi: 10.3748/wjg.v17.i6.766.

16.

Lower gastrointestinal tract cancer predisposition syndromes.

Shah NB, Lindor NM.

Hematol Oncol Clin North Am. 2010 Dec;24(6):1229-52. doi: 10.1016/j.hoc.2010.08.012. Review.

17.

Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.

Limburg PJ, Harmsen WS, Chen HH, Gallinger S, Haile RW, Baron JA, Casey G, Woods MO, Thibodeau SN, Lindor NM.

Clin Gastroenterol Hepatol. 2011 Jun;9(6):497-502. doi: 10.1016/j.cgh.2010.10.021. Epub 2010 Nov 5.

18.

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.

Sjursen W, Haukanes BI, Grindedal EM, Aarset H, Stormorken A, Engebretsen LF, Jonsrud C, Bjørnevoll I, Andresen PA, Ariansen S, Lavik LA, Gilde B, Bowitz-Lothe IM, Maehle L, Møller P.

J Med Genet. 2010 Sep;47(9):579-85. doi: 10.1136/jmg.2010.077677. Epub 2010 Jun 28.

19.

The inherited genetics of ovarian and endometrial cancer.

Gayther SA, Pharoah PD.

Curr Opin Genet Dev. 2010 Jun;20(3):231-8. doi: 10.1016/j.gde.2010.03.001. Epub 2010 Apr 24. Review.

20.

Survey of HNPCC Management Analysis of Responses from 18 International Cancer Centres.

Chow E, Macrae F, Burn J; respondents from 18 international ICG-HNPCC Familial Cancer Clinics.

Hered Cancer Clin Pract. 2005 Oct 15;3(4):137-46. doi: 10.1186/1897-4287-3-4-137.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk